1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Neurodegenerative Disease: new trials by email Literature Review of Neurodegenerative Disease trials Research Report on Neurodegenerative Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VR-based Physical Activity and Reminiscence Therapy aPAVRCT - Dementia, Neurodegenerative Disease | Phase 1 / Phase 2 | Not yet recruiting | Hong Kong University of Science and Technology | 100 | 2025-05-19 | 2025-05-22 |
| PET Tau - Neurodegenerative Disease Imaging 18F-AV-1451 - Neurodegenerative Disease | Phase 2 / Phase 3 | Recruiting | University of Pennsylvania | 300 | 2016-08-23 | 2026-10-16 |
| Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) Deferiprone - Neurodegenerative Disease, Iron Overload | Phase 2 | Unknown | Ente Ospedaliero Ospedali Galliera | 20 | 2008-11-01 | 2023-02-09 |
| Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System dextromethorphan - Neurodegenerative Disease, Parkinson's Disease | Phase 2 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 42 | 1993-07-01 | 2006-07-13 |
Neurodegenerative Diseases (4) · Cognitive Dysfunction (1) · Dementia (1) · Iron Overload (1) · Motor Activity (1) · Nerve Degeneration (1) · Parkinson Disease (1)
Nervous System Diseases (4) · Brain Diseases (2) · Central Nervous System Diseases (2) · Basal Ganglia Diseases (1) · Behavior (1) · Cognition Disorders (1) · Iron Metabolism Disorders (1) · Mental Disorders (1) · Metabolic Diseases (1) · Movement Disorders (1) · Neurocognitive Disorders (1) · Nutritional and Metabolic Diseases (1) · Parkinsonian Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · Deferiprone (1) · Dextromethorphan (1) · Solutions (1)
Ente Ospedaliero Ospedali Galliera (1) · Hong Kong University of Science and Technology (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · University of Pennsylvania (1)
United States (2) · Italy (1)
David Irwin, MD (1) · Gian Luca Forni, MD (1)